Prime Therapeutics welcomes Chris Knibb as Chief Financial Officer
Promotes Dave Schlett to executive vice presidentSeptember 28, 2021
EAGAN, Minn. – Chris Knibb, an accomplished finance executive with more than 25 years of financial and business leadership, has joined Prime Therapeutics LLC (Prime), as its new chief financial officer (CFO). In this role, Knibb will oversee Prime’s corporate finance area, including treasury and internal audit, supply chain economics, financial planning and analysis, as well as controller functions.
Knibb’s career has spanned a variety of industries including health care. He recently held the CFO position at SOC Telemed, an acute-care telemedicine company, and previously served as Express Scripts’ senior vice president of finance and chief accounting officer. He has also served in various financial leadership roles over the years for several public and privately held companies in technology, energy, and natural resources space.
Knibb (pictured at left) is a certified public accountant (CPA), holds a Bachelor of Arts degree, plus completed post-graduate courses in accounting from the University of South Florida, Tampa, Fla. Knibb is also a military veteran, having served in the United States Army.
Dave Schlett (pictured at right), who has served as Prime’s CFO the past two years, has also been promoted to an expanded role as executive vice president (EVP) – chief client relationship and administrative officer. Schlett joined Prime in January 2020 and brought expertise in finance, strategic planning, business development, and other business aspects, including those unique to the PBM industry. In his new role, he will continue to lead finance, pricing, underwriting, and analytics as well as oversee Prime’s growth and retention efforts.
“We are so fortunate to have the expertise of these two, highly-regarded health care leaders at Prime,” said Prime’s President and CEO Ken Paulus. “Both have a high level of business acumen and strong financial backgrounds which will serve Prime well in the future.”
December 5, 2023
EAGAN, Minn. – Today, Prime Therapeutics LLC/Magellan Rx Management LLC (Prime/MRx) announces that…
November 29, 2023
EAGAN, Minn. – Nov. 29, 2023 – Prime Therapeutics LLC (Prime) and Magellan…
October 16, 2023